Loading...
logo for musn129.com

CVS Chart

1 Month
Date
Diff
Articles
2025-05-02
-2.87 %
CVS Health (CVS) stock fell by 2.87% amid positive economic indicators lifting the broader stock market and concerns arising from its partnership with Novo Nordisk to distribute the Wegovy weight-loss drug at lower prices, which has created apprehension among Eli Lilly investors.
2025-05-01
+4.11 %
CVS Health's stock rose by 4.11% due to its announcement that it would include rival weight-loss drugs Wegovy and Saxenda on its preferred formulary while excluding Eli Lilly's Zepbound, potentially increasing the accessibility of these medications and enhancing CVS's market competitiveness.
2025-04-30
+2.58 %
CVS Health (CVS) stock rose 2.58% ahead of its upcoming earnings report, driven by positive analyst expectations for a significant year-over-year earnings increase and strong recent stock performance, despite bearish sentiment in options trading that may lead to a contrarian rally if earnings exceed projections.